News & Events

See what’s new at DiFilippo Corporate Finance Group

At DCF Group, we are continually working to advance the practice of financial and tax-related valuation issues to benefit our clients. Learn about new transactions, new staff members, industry news, and upcoming events. Check back often to see the latest updates.


Generation Bio Announces Closing of Initial Public Offering

Genetic medicines company announced the closing of its initial public offering of 12,105,263 shares of common stock. Read More

Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline

Cullinan Oncology announced Series B funding of $98.5 million, adding financial backing from institutional investors and family offices. Read More

Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered

Gene editing biotech Beam Therapeutics raised $180 million in its IPO after offering 48% more shares than anticipated. Read More

Black Diamond Therapeutics Doubles After $201 Million IPO

Black Diamond Therapeutics Inc. more than doubled in its trading debut after raising $201 million in an IPO that exceeded its goals. Read More